Phytohealth Corp - Asset Resilience Ratio

Latest as of September 2025: 44.51%

Phytohealth Corp (4108) has an Asset Resilience Ratio of 44.51% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of Phytohealth Corp for a breakdown of total debt and financial obligations.

Liquid Assets

NT$1.04 Billion

≈ $32.78 Million USD Cash + Short-term Investments

Total Assets

NT$2.34 Billion

≈ $73.65 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2002–2024)

This chart shows how Phytohealth Corp's Asset Resilience Ratio has changed over time. See 4108 book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Phytohealth Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 4108 stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	NT$0.00	0%
Short-term Investments	NT$1.04 Billion	44.51%
Total Liquid Assets	NT$1.04 Billion	44.51%

Asset Resilience Insights

Very High Liquidity: Phytohealth Corp maintains exceptional liquid asset reserves at 44.51% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Phytohealth Corp Industry Peers by Asset Resilience Ratio

Compare Phytohealth Corp's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Regencell Bioscience Holdings Ltd NASDAQ:RGC	Drug Manufacturers - Specialty & Generic	43.05%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	3.73%
Yuhan Corp. KO:000100	Drug Manufacturers - Specialty & Generic	0.99%
Tonghua Dongbao Pharmaceutical Co Ltd SHG:600867	Drug Manufacturers - Specialty & Generic	1.96%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Guobang Pharma Ltd SHG:605507	Drug Manufacturers - Specialty & Generic	8.47%

Annual Asset Resilience Ratio for Phytohealth Corp (2002–2024)

The table below shows the annual Asset Resilience Ratio data for Phytohealth Corp.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	43.35%	NT$1.06 Billion ≈ $33.32 Million	NT$2.44 Billion ≈ $76.86 Million	-7.85pp
2023-12-31	51.19%	NT$1.20 Billion ≈ $37.91 Million	NT$2.35 Billion ≈ $74.05 Million	-2.10pp
2022-12-31	53.30%	NT$1.26 Billion ≈ $39.71 Million	NT$2.36 Billion ≈ $74.50 Million	-0.17pp
2021-12-31	53.47%	NT$1.32 Billion ≈ $41.61 Million	NT$2.47 Billion ≈ $77.82 Million	+14.86pp
2020-12-31	38.61%	NT$698.66 Million ≈ $22.01 Million	NT$1.81 Billion ≈ $57.01 Million	+4.35pp
2019-12-31	34.25%	NT$644.66 Million ≈ $20.31 Million	NT$1.88 Billion ≈ $59.29 Million	+33.38pp
2018-12-31	0.87%	NT$18.02 Million ≈ $567.70K	NT$2.07 Billion ≈ $65.16 Million	-47.48pp
2017-12-31	48.35%	NT$1.06 Billion ≈ $33.39 Million	NT$2.19 Billion ≈ $69.07 Million	+4.22pp
2016-12-31	44.13%	NT$1.07 Billion ≈ $33.72 Million	NT$2.42 Billion ≈ $76.40 Million	+26.22pp
2015-12-31	17.91%	NT$419.00 Million ≈ $13.20 Million	NT$2.34 Billion ≈ $73.72 Million	-30.75pp
2014-12-31	48.65%	NT$1.21 Billion ≈ $38.15 Million	NT$2.49 Billion ≈ $78.42 Million	-1.00pp
2013-12-31	49.65%	NT$1.40 Billion ≈ $44.18 Million	NT$2.82 Billion ≈ $88.97 Million	+47.31pp
2012-12-31	2.35%	NT$67.69 Million ≈ $2.13 Million	NT$2.88 Billion ≈ $90.84 Million	-11.98pp
2011-12-31	14.33%	NT$236.51 Million ≈ $7.45 Million	NT$1.65 Billion ≈ $52.00 Million	-18.82pp
2010-12-31	33.15%	NT$632.06 Million ≈ $19.91 Million	NT$1.91 Billion ≈ $60.08 Million	-11.99pp
2009-12-31	45.14%	NT$954.21 Million ≈ $30.06 Million	NT$2.11 Billion ≈ $66.60 Million	+27.80pp
2008-12-31	17.34%	NT$186.78 Million ≈ $5.88 Million	NT$1.08 Billion ≈ $33.94 Million	-13.55pp
2007-12-31	30.89%	NT$480.49 Million ≈ $15.14 Million	NT$1.56 Billion ≈ $49.01 Million	+4.53pp
2004-12-31	26.36%	NT$80.45 Million ≈ $2.53 Million	NT$305.18 Million ≈ $9.61 Million	-25.81pp
2003-12-31	52.17%	NT$179.52 Million ≈ $5.66 Million	NT$344.09 Million ≈ $10.84 Million	+48.13pp
2002-12-31	4.04%	NT$6.30 Million ≈ $198.48K	NT$156.02 Million ≈ $4.92 Million	--

pp = percentage points

About Phytohealth Corp

TW:4108 Taiwan Drug Manufacturers - Specialty & Generic

Market Cap

$76.66 Million

NT$2.43 Billion TWD

Market Cap Rank

#20210 Global

#1186 in Taiwan

Share Price

NT$12.25

Change (1 day)

-0.81%

52-Week Range

NT$12.25 - NT$17.30

All Time High

NT$46.36